Kathryn J Collier Regulus Therapeutics Inc. (RGLS) insider trading activity

RGLS Quotes by TradingView

Kathryn J Collier is of Regulus Therapeutics Inc.. Currently has a direct ownership of 0 shares of RGLS, which is worth approximately $0. The most recent transaction as insider was on Jun 25, 2025, when has been sold 75,565 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Kathryn J Collier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
SELL
Sale (or disposition) back to the issuer
-
75,565 Reduced 100.0%
0 Common Stock
Jun 17 2025
BUY
Exercise of conversion of derivative security
$46,086 $9.35 p/Share
4,929 Added 7.27%
62,915 Common Stock
Jun 16 2025
BUY
Exercise of conversion of derivative security
$13,820 $9.9 p/Share
1,396 Added 2.02%
67,844 Common Stock
Apr 30 2025
BUY
Grant, award, or other acquisition
-
62,500 Added 47.44%
69,240 Common Stock
Jul 25 2024
BUY
Open market or private purchase
$7,280 $1.82 p/Share
4,000 Added 37.24%
6,740 Common Stock
KJC

Kathryn J Collier

San Diego, CA

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGLS